Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2022
Holdings of AMRX by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−1,583,490−100.0%Sold outHolders
Q4 20221,583,490$3.15M0.1%00.0%UnchangedHolders
Q3 20221,583,490$3.20M0.1%+1,583,490NewHolders